Filing Details

Accession Number:
0001209191-16-138310
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-23 16:28:22
Reporting Period:
2016-08-19
Filing Date:
2016-08-23
Accepted Time:
2016-08-23 16:28:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591950 Maher Albitar 12701 Commonwealth Drive Suite 9
Fort Myers FL 33913
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-19 200,000 $1.43 263,492 No 4 M Direct
Common Stock Acquisiton 2016-08-19 20,000 $3.45 283,492 No 4 M Direct
Common Stock Acquisiton 2016-08-19 100,000 $4.78 383,492 No 4 M Direct
Common Stock Acquisiton 2016-08-19 250,000 $1.43 633,492 No 4 M Direct
Common Stock Disposition 2016-08-19 370,000 $8.23 263,492 No 4 S Direct
Common Stock Disposition 2016-08-19 34,625 $8.26 228,867 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (Right to Buy) Disposition 2016-08-19 200,000 $1.43 200,000 $1.43
Common Stock Stock Option (Right to Buy) Disposition 2016-08-19 20,000 $3.45 20,000 $3.45
Common Stock Stock Option (Right to Buy) Disposition 2016-08-19 100,000 $4.78 100,000 $4.78
Common Stock Stock Option (Right to Buy) Disposition 2016-08-19 250,000 $1.43 250,000 $1.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-05-09 2017-01-09 No 4 X Direct
10,000 2015-03-05 2019-03-05 No 4 X Direct
200,000 2016-05-05 2020-05-05 No 4 X Direct
0 2013-01-09 2017-01-09 No 4 X Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 63,492 Indirect Shares owned by Albitar Oncology Defined Benefit Plan
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $7.15 2017-04-20 2021-04-20 200,000 200,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-04-20 200,000 200,000 Direct
Footnotes
  1. Shares withheld by NeoGenomics, Inc. to satisfy the cost of shares in connection with the August 19, 2016 warrant exercise.
  2. Closing stock price on date of exercise, August 19, 2016.
  3. These warrants were issued to Dr. Albitar upon the start of his service to the Company and vest upon the achievement of certain milestones.
  4. On March 5, 2014 Dr. Albitar was granted 30,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
  5. On May 5, 2015 Dr. Albitar was granted 300,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
  6. These stock options were granted upon the start of Dr. Albitar's service to the Company and vest ratably over each of his first four anniversaries with the Company.
  7. On April 20, 2016, Dr. Albitar was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.